TrialThe Journal of infectious diseases2012

Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

Corinna La Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.